Author | Jennifer Chan, MD, MPH | OncLive

Author | Jennifer Chan, MD, MPH

Articles

Dr. Chan on Trial of Cabozantinib in Neuroendocrine Tumors

November 16, 2017

Video

Jennifer Chan, MD, MPH, senior physician, clinical director, Program in Carcinoid and Neuroendocrine Tumors, Dana-Farber Cancer Institute, assistant professor of medicine, Harvard Medical School, discusses a trial of cabozantinib (Cabometyx) in neuroendocrine tumors (NETs).

x